EyePoint Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Revenue	46.02	41.4	36.94	34.44	20.37	2.96	7.54	1.62	26.57	3.47	Upgrade
Revenue Growth (YoY)	11.14%	12.09%	7.27%	69.10%	587.77%	-60.72%	365.37%	-93.90%	664.90%	62.06%	Upgrade
Cost of Revenue	4.63	8.33	8.18	5.82	2.69	0	0	0	0	0	Upgrade
Gross Profit	41.39	33.08	28.76	28.61	17.68	2.96	7.54	1.62	26.57	3.47	Upgrade
Selling, General & Admin	51.79	60.32	53.08	46.02	47.71	13.06	11.24	9.01	8.06	7.47	Upgrade
Research & Development	64.66	49.64	28.5	17.42	15.37	16.18	14.88	14.38	12.09	9.57	Upgrade
Other Operating Expenses	0	22.75	2.46	2.46	2.46	0	0	0	0	-0.08	Upgrade
Operating Expenses	116.45	132.72	84.04	65.9	65.54	29.24	26.12	23.39	20.14	16.96	Upgrade
Operating Income	-75.07	-99.64	-55.28	-37.29	-47.86	-26.27	-18.58	-21.77	6.42	-13.49	Upgrade
Interest Expense / Income	1.25	3.19	5.5	7.26	6.18	0.72	0	0	0	0	Upgrade
Other Expense / Income	-5.6	-0.57	-2.36	0.85	2.76	26.18	-0.09	-0.07	-0.02	-0.01	Upgrade
Pretax Income	-70.71	-102.25	-58.42	-45.39	-56.79	-53.17	-18.49	-21.7	6.44	-13.49	Upgrade
Income Tax	0.08	0	0	0	0	0	0	-0.16	0.1	-0.13	Upgrade
Net Income	-70.8	-102.25	-58.42	-45.39	-56.79	-53.17	-18.49	-21.55	6.35	-13.36	Upgrade
Shares Outstanding (Basic)	39	37	29	13	10	5	4	3	3	3	Upgrade
Shares Outstanding (Diluted)	39	37	29	13	10	5	4	3	3	3	Upgrade
Shares Change	4.25%	29.76%	124.04%	23.06%	125.65%	30.79%	11.77%	3.40%	11.44%	19.09%	Upgrade
EPS (Basic)	-1.82	-2.74	-2.03	-3.54	-5.44	-11.50	-5.20	-6.80	2.20	-4.90	Upgrade
EPS (Diluted)	-1.82	-2.74	-2.03	-3.54	-5.44	-11.50	-5.20	-6.80	2.10	-4.90	Upgrade
Free Cash Flow	-1.61	-67.16	-50.25	-14.8	-56.91	-22.02	-20.6	-16.43	10.14	-10.84	Upgrade
Free Cash Flow Per Share	-0.04	-1.80	-1.75	-1.15	-5.46	-4.76	-5.83	-5.20	3.45	-3.95	Upgrade
Gross Margin	89.93%	79.89%	77.86%	83.09%	86.81%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-163.13%	-240.65%	-149.64%	-108.28%	-235.02%	-887.34%	-246.40%	-1344.07%	24.17%	-388.42%	Upgrade
Profit Margin	-153.84%	-246.97%	-158.14%	-131.82%	-278.88%	-1795.71%	-245.19%	-1330.06%	23.89%	-384.54%	Upgrade
Free Cash Flow Margin	-3.49%	-162.19%	-136.04%	-42.97%	-279.46%	-743.50%	-273.30%	-1014.14%	38.16%	-312.15%	Upgrade
Effective Tax Rate	-	-	-	-	-	-	-	-	1.49%	-	Upgrade
EBITDA	-69	-96.62	-50.15	-35.49	-48.01	-51.3	-17.67	-20.79	7.33	-12.57	Upgrade
EBITDA Margin	-149.94%	-233.36%	-135.76%	-103.05%	-235.76%	-1732.62%	-234.38%	-1283.58%	27.57%	-361.88%	Upgrade
Depreciation & Amortization	0.46	2.45	2.77	2.65	2.6	1.15	0.82	0.91	0.88	0.92	Upgrade
EBIT	-69.47	-99.07	-52.92	-38.14	-50.62	-52.45	-18.49	-21.7	6.44	-13.49	Upgrade
EBIT Margin	-150.95%	-239.26%	-143.26%	-110.74%	-248.55%	-1771.39%	-245.19%	-1339.63%	24.25%	-388.28%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).